- Cuando el paciente está adaptado se realizarán los ajustes finales durante la noche, tratando de alcanzar los objetivos de reposo de los músculos inspiratorios y mejoría del intercambio gaseoso. Se debe constatar la eficacia de la VMNI (ventilación mecánica no invasiva) y realizar un seguimiento estricto durante los primeros meses.

Bibliografía

1. Pareyson D, Scaioli V, Laura M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med. 2006; 8: 3-22.
2. Aboussouan LS, Lewis RA, Shy ME. Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease. Lung 2007 Jan-Feb; 185 (1): 1-7.
3. Stojkovic T, Latour P, Viet G, Hurtevent JF, et al. Vocal cord and diadhragm paralysis, as clinical features of a French family with autosomal recessive Charcot-Marie-Tooh disease, associated with a new mutation in the GDAP1 gene. Neuromuscul Disord. 2004; 14: 261-264.
4. DeLisser HM. Respiratory failure from peripheral neuromuscular disease. In: Rose BD, editor. Wellesley: UpToDate, 2002.
5. Nathanson VN, Yu DG, Chan CK. Respiratory muscle weakness in Charct-Marie-Tooh disease. A field study. Arch Intern Med. 1989; 149: 1389-91.
6. Carter GT. Phrenic nerve involvement in Charcot-Marie-Thoot. Muscle Nerve. 1995; 18: 1215-1216.
7. Darquennes K, De Jonghe P, Daems D, De Backer W, Verbraecken J. Intermittent positive airway pressure by nasal mask as a treatment for respiratory insufficiency in a patient with Charcot-Marie-Tooth disease. Acta Clin Belg. 2006 Jul- Aug; 61(4): 176-81.
8. Turkington PM, Elliott MW. Rationale for the use of non-invasive ventilation in chronic ventilatory failure. Thorax 2000; 55: 417-23.